Back to today’s briefing

Story perspectives

New Cancer Compounds Identified Through Advanced ADMET Profiling

10/8/2025

43 4 Full Breakdown

Summary

Story summary

ADMET profiling of BRPF1b hits shows compounds 1–4 are stable in microsomes and hepatocytes, supporting use in poly-medicated cancer patients.
A streamlined workflow identified 51 in silico hits from 24 million compounds, with 36 verified as primary binders and four BRPF1b hits orthogonally validated.
Delta4 knowledge graph-based astrocyte model integrates 275 core genes and adds neurotoxic and neuroprotective phenotypes.

1 of 1

Story summary

ADMET profiling of BRPF1b hits shows compounds 1–4 are stable in microsomes and hepatocytes, supporting use in poly-medicated cancer patients.
A streamlined workflow identified 51 in silico hits from 24 million compounds, with 36 verified as primary binders and four BRPF1b hits orthogonally validated.
Delta4 knowledge graph-based astrocyte model integrates 275 core genes and adds neurotoxic and neuroprotective phenotypes.